
The pharmaceutical industry stands on the brink of a revolution, one that is being driven by the ever-evolving capabilities of artificial intelligence (AI). From accelerated drug discovery to the inception of personalized medicine, AI is not just redefining what is possible but is also streamlining operations, shaving years off development timelines, and opening up new avenues for treating diseases. This









